17 Feb 20 (FOURTH article in a series)
With firm evidence that George Soros, Gilead Sciences and UNITAID desired to penetrate China’s closed pharmaceutical market with patent-sharing strategies, additional evidence emerges on a coronavirus patent holder.
THIS article on the coronavirus, which is the third of six articles and contains links to the first two, provides the backstory to the developments being written about here in this fourth article. The backstory is important for context and I would encourage you to read the articles – they’re relatively short. The third article in particular contains even deeper background information on the role of the virus throughout history; especially as a weapon, as provided by Jon Rappoport.
The meat and potatoes/Cliff’s Notes version of those three articles reads like this – I tracked all of it back to George Soros, Gilead Sciences and Unitaid, which were working to penetrate China’s closed pharmaceutical market with patent-sharing strategies that could produce enormous royalties going back to the patent holders. Gilead specifically was looking to overcome stagnant products and expiring patent protections resulting in losses. In this case it’s Gilead Sciences which holds the patent on Remdesivir, which is the only known effective treatment at this time.
It’s the patent angles we’re tracking and these are the vectors: Gilead Sciences (holds the patent and goes back to GlaxoSmithKline), GSK (is a Rothschild’s owned corporation), Unitaid (NGO funded by George Soros and brokers patent-sharing deals), George Soros (funding Unitaid and the patent-sharing efforts in select African Nations while looking to penetrate China’s (and Brazil’s) closed markets for the same purpose. Beyond that, I suggest reading the articles.
Stay focused on the patents, here, because they’re introducing another billionaire, also another vector(s) to the fold. Quick sidebar – I find it troubling that there are two billionaires yanking on the same end of the coronavirus rope (or shall we say construct since the evidence is portending that. The dam that is an authentic outbreak has entirely too many holes to plug a this point.)
With a h/t to @Shazlandia (Twitteer/Gab) for keeping the evidence furnace fired with coal, consider what James Fetzer is now reporting in THIS article (emphasis mine),
In this report we take an inside look at Event 201, which took place in NYC on October 18 2019.
Event 201 is a high-level pandemic exercise hosted by the Johns Hopkins Center for Health Security in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation.
This is extremely fascinating because this pandemic simulation exercise of coronavirus took place about 6 weeks before the first illness from the coronavirus was actually reported in Wuhan, China.
That is one hell of a coincidence if you believe in that sort of thing.
Another fascinating connection is the fact that not only did the Bill and Melinda Gates Foundation participate in and help set up the pandemic simulation of a coronavirus outbreak, but they just so happen to fund the group who owns the patent to the deadly coronavirus and are already working on a vaccine to solve the current crisis.JAMES FETZER
So, not only is billionaire and global string puller George Soros standing to benefit from this “outbreak” of coronavirus in Wuhan, China, so does billionaire and global string puller Bill Gates. Gates and his foundation just happened to have funded and participated in an exercise/drill simulating specifically a coronavirus outbreak some 6-weeks prior to the actual one. Not only that, Gates also happens to financially back the Pirbright Institute, which happens to own a patent for a strand of the coronavirus that may (will likely) provide a cure (vaccine) that is sure to also produce a king’s ransom. (SOURCE)
Here’s a pile of facts for you. A dead Canadian scientist who specialized in the coronavirus and bio-warfare. Evidence of 4 HIV insertions into the coronavirus strain suggesting bio-engineering with implications for bio-warfare. Evidence showing that the virus “leaked” from a nearby laboratory in Wuhan. A coronavirus drill 6 weeks before the actual outbreak; one funded by a billionaire with a vested interest in the coronavirus patent. Another billionaire with an NGO specializing in patent-sharing strategies and a stated desire to expand into China whereby the NGO’s own board voted down on the matter.
Now we have patent-sharing negotiations currently taking place between China and these pharmaceutical corporations whereby the the corporations get to retain their patents. Does this reflect WHY Unitaid’s board voted down on the Chinese expansion? Was that decision not related to pressure from Big Pharma to protect those prized markets (plus Brazil)? Did they vote no because it was understood that it was no longer needed and rather a more tangible, critical and authentic reason would happen; and seemingly by design, which is what I’m obviously implying here?
That’s a whole bunch of timing and convergence if you ask me. We didn’t even discuss the economic aspects here, which are brushed over in the third article.
At this point, the bulk of the evidence sends us in a direction different than what the MSM and federal government is telling us. The evidence seems to tie all of it back to billionaires and patents and that’s the vector to the truth.
[…] from this site on the coronavirus and patent-sharing strategies, I highly encourage you to start HERE because it links back to all of the previous work and more importantly, it gives you the backdrop […]
Reblogged this on kommonsentsjane and commented:
Reblogged on kommonsentsjane/blogkommonsents.
For your information.
[…] https://politicalmoonshine.com/2020/02/17/further-evidence-that-patents-and-patent-sharing-are-entir… […]
[…] FOURTH ARTICLE […]
[…] FOURTH ARTICLE: […]
[…] FOURTH ARTICLE: […]
[…] FOURTH ARTICLE: […]
Is there a way to get the same surveillance video camera angle of the controlled demolition and thread it together with the first collapse of the south tower
[…] hanging my hat on Dr. Martin because I established in the FIRST SECOND FOURTH FIFTH and SEVENTH articles [and others] from this massive series that patents and patent sharing […]